Allergies are a type of hypersensitivity reaction caused by the immune system. There are many types of allergies. You can be ...

DBV Technologies Announces Positive 3-Year Results from EPITOPE Phase 3 Open-Label Extension Study EPITOPE OLE data demonstrates continued improvement in treatment ...

Canada and United Kingdom represent two of the largest markets within the ALK portfolio with plans to expand filings of neffy (epinephrine nasal ...

Request To Download Free Sample of This Strategic Report @ This country research report on Vietnam Epinephrine Autoinjector Market offers comprehensive insights into the market landscape, customer ...

Roy Khalaf, from McGill University in Montreal, and colleagues examined sociodemographic characteristics, clinical symptoms, and management of anaphylaxis among adults in a cross-sectional study.

In terms of management, TIA was more likely associated with inpatient epinephrine (adjusted odds ratio, 2.05), while DIA and TIA were less and more likely associated with outpatient antihistamine, ...

epinephrine nasal spray became the first nasal spray to treat anaphylaxis, an exciting statement for those who encounter life-threatening allergic reactions and are also afraid of injection treatments ...

(previously referred to as ARS-1), an epinephrine nasal spray indicated in the U.S. for emergency treatment of Type I allergic reactions, including anaphylaxis, in adult and pediatric patients who ...

In the absence of clinical improvement or if symptoms worsen after initial treatment, administer a second dose ... anaphylaxis, but (in 2023, for example) only 3.2 million filled their active ...